美国医生治疗高血压时的药品选择  

The choice of antihypertensive medicines by American physicians

作　　者：白炯[1] 

机构地区：[1]河南科技大学第二附属医院,河南洛阳471003

出　　处：《中国医院药学杂志》2008年第5期382-384,共3页Chinese Journal of Hospital Pharmacy

摘　　要：目的:分析美国医生在治疗高血压时的不同种类的药品使用情况,以便我国的医生借鉴。方法:利用美国国家疾病和治疗索引中的数据,对1990-2004年间美国医生在治疗高血压时利尿剂、α受体阻滞剂、β受体阻滞剂、血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂、钙通道阻滞剂和中枢降压药等类药品的使用情况进行统计比较。结果:血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂呈上升趋势,钙通道阻滞剂、利尿剂和β受体阻滞剂变化不大,α受体阻滞剂和中枢降压药使用越来越少。在2004年,使用比例从高到低依次为:血管紧张素转换酶抑制剂、利尿剂、钙通道阻滞剂、血管紧张素Ⅱ受体拮抗剂、β受体阻滞剂、α受体阻滞剂、中枢降压药。结论:用药指南和最新的研究报告对医生的用药行为有一定的影响,但是作用有限。OBJECTIVE The percentages of different types of antihypertensive medicines used by the American physicians was analyzed, and the results can be refered to by physicians in China. METHODS The data in the National Disease and Therapeutic Index were used to statistic the percentages of different types of antihypertensive medicines used in USA during 1990- 2004, such as β-blockers, thiazide/other direutics, α-blockers, ACEI, ARBs, CCBs and central acting agents etc. RESULTS ACEI and ARBs kept rising while α-blockers and central acting kept descending, and CCBs, β-blockers and thiazide/other direutics had a little changes. In 2004, ACEI was used most frequently, then thiazide/other direutics, CCBs, ARBs, β-blockers, α- blockers and central acting agents. CONCLUSION The JNC reports and the new research results have influence on physicians, but the influence is limited.

关 键 词：高血压 药物 美国医生 

分 类 号：R972.4[医药卫生—药品]